Absence of 4-1BB reduces obesity-induced atrophic response in skeletal muscle

Ngoc Hoan Le1, Chu-Sook Kim1, Thai Hien Tu1

  • 1Department of Food Science and Nutrition, University of Ulsan, Ulsan, 44610 South Korea.

Insights

Blocking 4-1BB signaling in obesity reduces skeletal muscle atrophy and improves oxidative metabolism. This suggests 4-1BB is a potential therapeutic target for obesity-related metabolic dysfunction.

Area of Science:

  • Muscle Biology
  • Metabolic Diseases
  • Immunology

Background:

  • Obesity triggers skeletal muscle atrophy and metabolic dysfunction, linked to inflammation.
  • 4-1BB (tumor necrosis factor receptor superfamily member) was previously implicated in obesity-related muscle inflammation.

Purpose of the Study:

  • To investigate the role of 4-1BB in obesity-induced skeletal muscle atrophy and metabolic changes.
  • To determine if targeting 4-1BB can ameliorate these effects.

Main Methods:

  • Utilized obese mice fed a high-fat diet.
  • Assessed the impact of 4-1BB absence on skeletal muscle atrophic factors (MuRF1, Atrogin-1) and NF-κB activity.
  • Analyzed changes in mitochondrial oxidative metabolic genes/proteins (e.g., PGC-1α, CPT1β) and oxidative muscle fiber markers.

Main Results:

  • Absence of 4-1BB decreased expression of atrophic factors (MuRF1, Atrogin-1) in skeletal muscle.
  • NF-κB activity was suppressed in 4-1BB-deficient obese mice.
  • Mitochondrial oxidative metabolic gene/protein expression and oxidative muscle fiber markers were increased.

Conclusions:

  • 4-1BB-mediated inflammatory signaling contributes to obesity-related skeletal muscle atrophy and metabolic derangement.
  • Targeting 4-1BB may offer a therapeutic strategy for combating muscle atrophy and metabolic complications in obesity.